Clinical Trial Update: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the efficacy and safety of TQH3906 capsules for active psoriatic arthritis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• TQH3906

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Psoriatic Arthritis | Phase 2 | Status: NOT_YET_RECRUITING